Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia

ConclusionZoledronic acid should be studied as a potential first-line agent for sarcoid hypercalcemia. Furthermore, disease-modifying effects of zoledronic acid in sarcoidosis should be investigated.

http://link.springer.com/10.1007/s11657-017-0360-1

Source: Archives of Orthopaedic and Trauma Surgery - July 19, 2017 Category: Orthopaedics Source Type: research